Published in

Elsevier, International Journal of Antimicrobial Agents, 2(52), p. 287-292

DOI: 10.1016/j.ijantimicag.2018.04.001

Links

Tools

Export citation

Search in Google Scholar

Molecular β-lactamase characterization of Gram-negative pathogens recovered from patients enrolled in the ceftazidime-avibactam phase 3 trials (RECAPTURE 1 and 2) for complicated urinary tract infections: Efficacies analysed against susceptible and resistant subsets

Journal article published in 2018 by Rodrigo E. Mendes ORCID, Mariana Castanheira, Leah N. Woosley, Gregory G. Stone, Patricia A. Bradford ORCID, Robert K. Flamm
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO